Press Releases

Raremark® launches the Xperiome™ patient-powered knowledge platform to deliver new therapies faster and smarter

Raremark®, the leading online patient community in rare disease, has today launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new therapies faster and smarter.

Notable Launches New Clinical Study With Washington University School of Medicine Exploring Ex Vivo Drug Screening to Predict Chemotherapy Sensitivity and Resistance

Notable announces a new precision oncology study with Washington University School of Medicine in St. Louis, exploring the feasibility of ex vivo drug screening to predict sensitivity and resistance to chemotherapy, and to identify novel synergies across a broad panel of anticancer therapies.

Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite

AI-powered investigator site intelligence platform allows users to select top-performing investigators worldwide and save up to $2.4m per trial on non-performing sites

CD Genomics Announces Advanced CDAMP® Panel Kits for SARS-CoV-2 Detection

CD Genomics Launches Complete Product Portfolio for Research to COVID-19 Response

Cell-Based Solutions for Tumor Research Are Available by Creative Proteomics’s Tumomics Platform

Creative Proteomics Introduces Advanced Gut Metatranscriptome Analysis Solutions

Creative Enzymes Optimizes Screening of Enzyme Activators for Enzyme Profiling

IM Therapeutics Expands Management Team with Appointments of Tom Shea as CFO/COO and Dr. Sarah Bird as VP, Clinical Development

Creative Enzymes Optimizes Enzyme Stabilization and Formulation Services

Alfa Chemistry Testing Lab Provides Customized Pharmaceutical Analytical Services

Alfa Chemistry Testing Lab announced today that it has recently launched customized pharmaceutical analytical services for companies involved with new drug development.

CD Genomics Announces MicroCollect™ FDA&CE Certificated Virus Collection Swab Kits for SARS-CoV-2 Detection

FHI CLINICAL INC. PROVIDING CLINICAL OPERATIONS SERVICES FOR ACTT-1 TRIAL OF REMDESIVIR FOR TREATMENT OF COVID-19

FHI Clinical announced today a subcontract with the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., to provide clinical operations services for the Adaptive COVID-19 Treatment Trial (ACTT). Supported by the NIAID, part of the NIH, the ongoing ACTT study is a randomized, double-blinded, placebo-controlled trial to allow investigation of putative therapeutics for the treatment of COVID-19 in hospitalized adults.

Elligo Launches Expanded System of Accelerated Research (SOAR™)

Elligo Health Research®, a healthcare-enabling research organization, is launching their fully realized System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.

Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial

Elucid’s Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time.

Profacgen Updated Its CLIP-Seq Service for RNA-Protein Interaction Study

Creative Biostructure Released Cryo-EM for Gene Therapy

Creative BioMart Updated Its Bacterial Expression Systems for Protein Expression Service

Creative Bioarray Release Validated Preclinical Models to Support All Stages of Drug Discovery

Research Presentation Strategies Announces New System Enabling the First-Ever Full Day Virtual FDA Drug Approval AdComm Presentation

Research Presentation Strategies (RPS), the leader in FDA advisory committee (AdComm) presentation support, announced the use of their technology platform for a successful virtual Cardio-Renal Drug Advisory Committee (CRDAC) meeting that took place on July 15, 2020. The RPS platform was utilized by a sponsor last week for the first fully virtual, day-long drug approval AdComm presentation.